Cooperative Research for Hazardous Materials Transportation

Cooperative Research for Hazardous Materials Transportation
Author: National Research Council (U.S.). Transportation Research Board. Committee for a Study of the Feasibility of a Hazardous Materials Transportation Cooperative Research Program
Publisher: Transportation Research Board
Total Pages: 171
Release: 2005
Genre: Hazardous substances
ISBN: 0309094976

Emergency Response Guidebook

Emergency Response Guidebook
Author: U.S. Department of Transportation
Publisher: Simon and Schuster
Total Pages: 352
Release: 2013-06-03
Genre: House & Home
ISBN: 1626363765

Does the identification number 60 indicate a toxic substance or a flammable solid, in the molten state at an elevated temperature? Does the identification number 1035 indicate ethane or butane? What is the difference between natural gas transmission pipelines and natural gas distribution pipelines? If you came upon an overturned truck on the highway that was leaking, would you be able to identify if it was hazardous and know what steps to take? Questions like these and more are answered in the Emergency Response Guidebook. Learn how to identify symbols for and vehicles carrying toxic, flammable, explosive, radioactive, or otherwise harmful substances and how to respond once an incident involving those substances has been identified. Always be prepared in situations that are unfamiliar and dangerous and know how to rectify them. Keeping this guide around at all times will ensure that, if you were to come upon a transportation situation involving hazardous substances or dangerous goods, you will be able to help keep others and yourself out of danger. With color-coded pages for quick and easy reference, this is the official manual used by first responders in the United States and Canada for transportation incidents involving dangerous goods or hazardous materials.

Forum on Future Directions in Transportation R & D

Forum on Future Directions in Transportation R & D
Author: National Research Council (U.S.). Transportation Research Board
Publisher: Transportation Research Board
Total Pages: 184
Release: 1995
Genre: Business & Economics
ISBN: 9780309061674

The National Science and Technology Council (NSTC) is conducting a comprehensive review of federal research and development (R & D) activities. To conduct the R & D review in the area of transportation, NSTC has established the Committee on Transportation Research and Development. The committee requested that the Transportation Research Board (TRB) convene a special forum to gather input from a group that broadly represents transportation providers and customers of new transportation technology and concepts. More than 170 representatives from the scientific and engineering community, the private sector, Congress, state and local government, academia, and transportation stakeholders participated in this forum. The objectives of the forum were to (a) obtain input from various segments of the transportation community on their particular federal R & D needs, (b) define an approach for the systematic and objective evaluation of R & D strategies and priorities, and (c) solicit comments and perspectives on a prepublication version of the Strategic Planning Document, prepared by the NSTC committee. This publication contains the proceedings of the forum. It is organized as follows: Executive Summary; Chairman's Remarks; Plenary Sessions; Breakout Sessions; Closing Remarks; and Appendix.

Research and Development in the Pharmaceutical Industry (A CBO Study)

Research and Development in the Pharmaceutical Industry (A CBO Study)
Author: Congressional Budget Office
Publisher: Lulu.com
Total Pages: 65
Release: 2013-06-09
Genre: Science
ISBN: 1304121445

Perceptions that the pace of new-drug development has slowed and that the pharmaceutical industry is highly profitable have sparked concerns that significant problems loom for future drug development. This Congressional Budget Office (CBO) study-prepared at the request of the Senate Majority Leader-reviews basic facts about the drug industry's recent spending on research and development (R&D) and its output of new drugs. The study also examines issues relating to the costs of R&D, the federal government's role in pharmaceutical research, the performance of the pharmaceutical industry in developing innovative drugs, and the role of expected profits in private firms' decisions about investing in drug R&D. In keeping with CBO's mandate to provide objective, impartial analysis, the study makes no recommendations. David H. Austin prepared this report under the supervision of Joseph Kile and David Moore. Colin Baker provided valuable consultation...